ACRYSOF® Toric NATURAL T9 Intraocular Lens (IOL)

NCT00967473 | Completed Results

• 1 other identifier: C-08-062
• Study Type: interventional
• Target: 15
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to describe rates of spatial distortions related to intraocular lens (IOL) misalignment for ACRYSOF® Single-Piece Toric NATURAL IOL Model SN60T9 when implanted bilaterally into the capsular bag following phacoemulsification in adult patients with bilateral cataract and regular corneal astigmatism. Subjects were implanted with the Model SN60T9 in the first operative (study) eye and either Model SN60T9 or Model SN60T8 in the second operative eye.

Conditions

Bilateral Cataract

Keywords

Astigmatism; cataract; corneal astigmatism; IOL; AcrySof

Outcome Measures

Primary Outcomes (3)

• Number of Subjects Reporting Spatial Distortions Related to Intraocular Lens (IOL) Misalignment

  Rates of spatial distortions were evaluated by use of the Visual Distortion Questionnaire (VDQ). The VDQ evaluates the rate \& frequency of subjects' experiences with potential visual distortions. The fewer the patients that report visual distortions, the better. The VDQ is a binocular assessment, therfore the subject will use both eyes to evaluate visual distortions.

  Before Surgery and 180 days after second eye implant

• Reduction of Cylinder

  Percentage of subjects with reduction in post-operative refractive cylinder (amount of astigmatism) compared to pre-operative keratometric cylinder in the study eye. The post-operative refractive cylinder should be significantly lower than it was pre-operatively.

  6 months after surgery on second eye

• Lens Axis Misalignment

  Comparison of where the surgeon intended to place the lens axis versus final placement of the lens during the surgical procedure, measured in degrees. This number should be close to zero as there should be minimal difference between the two numbers. This assessment is only for the study eye.

  Time of surgery

Study Arms (1)

Toric Intraocular Lens

EXPERIMENTAL

ACRYSOF® Single-Piece Toric NATURAL Intraocular Lens (IOL) Models SN60T9/SN60T8

Device: ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8.

Interventions

ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8. DEVICE

ACRYSOF® Single-Piece Toric NATURAL Intraocular Lens (IOL) Model SN60T9 in the first eye and either the ACRYSOF® Single-Piece Toric NATURAL IOL Model SN60T9 or Model SN60T8 in the second eye.

Toric Intraocular Lens

Eligibility Criteria

• Age: 21 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults, 21 years of age or older at the time of surgery, of either gender or any race, diagnosed with bilateral cataracts;
• Calculated lens power is within the available range;
• Willing and able to complete all required postoperative visits;
• Planned cataract removal by phacoemulsification;
• Potential postoperative visual acuity of 0.2 logMAR or better in study eyes;
• Preoperative astigmatism of 4.11 - 4.62 Diopter (D) of predicted crossed cylinder as calculated by the study specific web-based Alcon® Toric IOL Calculator in the first operative eye. Corneal incisions made to reduce astigmatism will not be allowed during the course of the study;
• Preoperative astigmatism of 3.60 - 4.62 D of predicted crossed cylinder as calculated by study specific web-based Alcon® Toric IOL Calculator in the second operative eye;
• Clear intraocular media other than cataract;
• Able to comprehend and sign a statement of informed consent;
• Preoperative Best Corrected Distance Visual Acuity (BCDVA) worse than 0.2 logMAR;
• Pupil size greater than or equal to 6 mm after dilation;
• The subject must be able to undergo second eye surgery within 30 days of first eye surgery.

You may not qualify if:

• Irregular corneal astigmatism;
• Keratopathy/Keratectasia - any corneal abnormality, other than regular corneal astigmatism, including but not limited to the following; keratoconus, keratoglobus, keratolysis, keratomalacia, keratomycosis, and corneal plana;
• Any inflammation or edema (swelling) of the cornea, including but not limited to the following; keratitis, keratoconjunctivitis, and keratouveitis;
• Previous corneal refractive surgery;
• Subjects with diagnosed degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that are predicted to cause future acuity losses to a level worse than 0.2 logMAR;
• Amblyopia;
• Clinically severe corneal dystrophy (e.g., epithelial, stromal, or endothelial dystrophy);
• Diabetic retinopathy;
• Extremely shallow anterior chamber, not due to swollen cataract;
• Microphthalmos;
• Previous retinal detachment;
• Previous corneal transplant;
• Recurrent severe anterior or posterior segment inflammation of unknown etiology;
• Rubella or traumatic cataract;
• Iris neovascularization;

Sponsors & Collaborators

• Alcon Research: lead

Study Sites (1)

Alcon Call Center for Trial Locations

Fort Worth, Texas, 76134, United States

Location

MeSH Terms

Conditions

Cataract; Astigmatism

Condition Hierarchy (Ancestors)

Lens Diseases; Eye Diseases; Refractive Errors

Results Point of Contact

• Title: Director of Alcon Clinical
• Organization: Alcon Research, Ltd.

medinfo@alconlabs.com

888-451-3937; 817-568-6725

Publication Agreements

• PI is Sponsor Employee: No
• Restriction Type: OTHER
• Restrictive Agreement: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 25, 2009
• First Posted: August 27, 2009
• Study Start: August 1, 2009
• Primary Completion: May 1, 2010
• Study Completion: May 1, 2010
• Last Updated: January 9, 2017
• Results First Posted: July 22, 2011

Record last verified: 2011-06

Locations

US (1)